To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

NCT06204991 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage III
Melanoma Stage IV
Melanoma

Interventions

BIOLOGICAL: ADP-TILIL7
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
DRUG: Proleukin

Sponsor

Inge Marie Svane

Collaborators

[object Object]